Health: Oncology News

Today is March 19, 2024. All times in Eastern Daylight Time.

Crown Bioscience Recognized Once Again as T+ Employer® for the Third Year in a Row

03/18/2024 - 08:30 PM

BUSINESS WIRE
冠科生物连续三年荣膺T+ Employer® 卓越雇主

03/18/2024 - 08:30 PM

BUSINESS WIRE
Crown Bioscienceが3年連続でT+ Employer®に認定される

03/18/2024 - 08:30 PM

BUSINESS WIRE
Lantern Pharma Reports Fourth Quarter & Fiscal Year 2023 Financial Results and Business Highlights

03/18/2024 - 04:02 PM

BUSINESS WIRE
Immunis Chairman Dr. Hans Keirstead to Present Abundance360 Moonshot

03/18/2024 - 03:32 PM

BUSINESS WIRE
Global Ventilators Market Focused Insights and Outlook 2024-2029 - KoninKlijke Philips, Hamilton Medical, Resmed, Medtronic & GE Healthcare Lead the Market - ResearchAndMarkets.com

03/18/2024 - 12:26 PM

BUSINESS WIRE
Global Liquid Biopsy Market Forecast Reveals a 15.2% CAGR Growth Through 2035 Amid Rising Demand for Non Invasive Cancer Diagnostics - ResearchAndMarkets.com

03/18/2024 - 09:10 AM

BUSINESS WIRE
GRAIL Announces Novel Risk Classification Test to Be Used in Lung Cancer Study

03/18/2024 - 09:00 AM

BUSINESS WIRE
Eureka Therapeutics Advances ARYA-3 Clinical Trial to Phase II for Treatment of Liver Cancer Using GPC3-Targeting ARTEMIS® T-cell Therapy

03/18/2024 - 08:02 AM

BUSINESS WIRE
Inocras Inc. Unveils Rebranding of Genome Insight

03/18/2024 - 08:00 AM

BUSINESS WIRE
Global Patient Survey Results Reveal Significant Negative Impact on Social, Emotional and Mental Well-Being for People Living with Low-Grade Serous Ovarian Cancer

03/18/2024 - 07:00 AM

BUSINESS WIRE
Natera Announces Phase III Randomized CIRCULATE Trial in France, Evaluating Signatera™ in Stage II Colorectal Cancer

03/18/2024 - 07:00 AM

BUSINESS WIRE
Tango Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Highlights

03/18/2024 - 07:00 AM

BUSINESS WIRE
Arrayjet’s ArrayPlex Platform Selected by Immunome for Use in Its Discovery of Targeted Cancer Therapies

03/18/2024 - 05:44 AM

BUSINESS WIRE
BeiGene、化学療法後の進行性または転移性食道扁平上皮癌の治療のためのTEVIMBRA®のFDA承認取得

03/16/2024 - 11:18 AM

BUSINESS WIRE
Positive RUBY phase III data show potential for Jemperli (dostarlimab-gxly) combinations in more patients with primary advanced or recurrent endometrial cancer

03/16/2024 - 08:00 AM

BUSINESS WIRE
百濟神州喜獲FDA批准，TEVIMBRA®將用於晚期或轉移性食管鱗狀細胞癌在化療後的治療

03/15/2024 - 05:13 PM

BUSINESS WIRE
New Study Shows that the Drug-Drug Interactions and Lifestyle Factors Provided by Castle Biosciences’ IDgenetix® Test Significantly Improve Medication Recommendations Over Drug-Gene Interactions Alone for Patients 65 and Older

03/15/2024 - 04:30 PM

BUSINESS WIRE
Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Operating and Financial Results

03/15/2024 - 04:05 PM

BUSINESS WIRE
BeiGene recebe aprovação da FDA para TEVIMBRA® para tratamento de câncer espinocelular de esôfago avançado ou metastático após quimioterapia prévia

03/15/2024 - 04:02 PM

BUSINESS WIRE
BeiGene reçoit l'approbation de la FDA pour TEVIMBRA® dans le traitement du carcinome épidermoïde de l’œsophage avancé ou métastatique après une chimiothérapie

03/15/2024 - 04:02 PM

BUSINESS WIRE
CARVYKTI® (ciltacabtagene autoleucel) Receives Recommendation from the U.S. FDA Oncologic Drugs Advisory Committee for Earlier Treatment of Patients with Relapsed/Refractory Multiple Myeloma

03/15/2024 - 03:15 PM

BUSINESS WIRE
United States Cancer Contrast Media (Gadolinium, Iodinated) Market Size, Share & Trends Analysis Report 2024-2030 - ResearchAndMarkets.com

03/15/2024 - 11:52 AM

BUSINESS WIRE
BeiGene recibe la aprobación de la FDA para TEVIMBRA ® para el tratamiento del carcinoma esofágico de células escamosas avanzado o metastásico luego de una quimioterapia previa

03/15/2024 - 10:41 AM

BUSINESS WIRE
Lantern Pharma Announces Initial Patients Dosed in First-In-Human Clinical Trial for AI-Guided Drug-Candidate, LP-284

03/15/2024 - 08:00 AM

BUSINESS WIRE

1 2 3 4 5 6 7 8 9 10 11 ... 19

Next »

Search